Pulmatrix, Inc. Files 8-K on Shareholder Nominations
Ticker: PULM · Form: 8-K · Filed: Oct 8, 2024 · CIK: 1574235
Sentiment: neutral
Topics: shareholder-nomination, governance, annual-meeting
TL;DR
Pulmatrix filed an 8-K: shareholders are nominating directors for the annual meeting.
AI Summary
Pulmatrix, Inc. filed an 8-K on October 8, 2024, reporting shareholder nominations for its upcoming annual meeting. The filing indicates that the company received nominations from shareholders for director positions, a standard procedural step for companies holding annual shareholder meetings.
Why It Matters
This filing is a routine procedural update, indicating that shareholders are actively participating in the governance of Pulmatrix, Inc. by nominating candidates for the board of directors.
Risk Assessment
Risk Level: low — The filing is a routine procedural disclosure related to shareholder nominations for an annual meeting and does not involve significant financial or operational changes.
Key Players & Entities
- Pulmatrix, Inc. (company) — Registrant
- October 3, 2024 (date) — Earliest event reported
- October 8, 2024 (date) — Date of report
- 945 Concord Street, Suite 1217, Framingham, MA 01701 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Pulmatrix, Inc.?
The primary purpose of this 8-K filing is to report shareholder nominations for director positions for the company's upcoming annual meeting.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on October 3, 2024.
What is the address of Pulmatrix, Inc.'s principal executive offices?
The address of Pulmatrix, Inc.'s principal executive offices is 945 Concord Street, Suite 1217, Framingham, MA 01701.
What is the company's state of incorporation?
Pulmatrix, Inc. is incorporated in Delaware.
What is the SIC code for Pulmatrix, Inc.?
The Standard Industrial Classification (SIC) code for Pulmatrix, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 809 words · 3 min read · ~3 pages · Grade level 16.4 · Accepted 2024-10-08 16:48:35
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share PULM The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- 0001493152-24-040453.txt ( ) — 209KB
- pulm-20241003.xsd (EX-101.SCH) — 3KB
- pulm-20241003_lab.xml (EX-101.LAB) — 33KB
- pulm-20241003_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PULMATRIX, INC. Date: October 8, 2024 By: /s/ Peter Ludlum Peter Ludlum Interim Chief Executive Officer and Interim Chief Financial Officer